| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $61.7M | — | +18.2% |
| R&D Expense | $2.7M | — | -19.7% |
| SG&A Expense | $12.8M | — | +146.2% |
| Operating Income | -$7.1M | — | -556.9% |
| Pre-tax Income | -$6.2M | — | -1501.8% |
| Income Tax | $124K | — | +0.8% |
| Net Income | -$6.3M | — | -2083.0% |
| EPS (Basic) | -$0.04 | — | — |
| EPS (Diluted) | -$0.04 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $31.4M | -15.9% | -47.7% |
| Accounts Receivable | $23.6M | +46.9% | +78.1% |
| Current Assets | $110.5M | -0.5% | -11.0% |
| Total Assets | $136.2M | +1.0% | +1.5% |
| Current Liabilities | $22.8M | +31.1% | +19.3% |
| Total Liabilities | $23.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.4M | — | -256.6% |
| Investing Cash Flow | -$793K | — | +91.2% |
| Financing Cash Flow | -$730K | — | +88.5% |
| +11.1% |
| Stockholders' Equity | $113.1M | -3.4% | -0.3% |